AZISHIL 100MG INJECTION

Content Reviewed By:

Written By:

• In Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), the emergence of tumor cells stems from transcriptional repression, a process where gene expression is silenced due to DNA hypermethylation. This hypermethylation essentially acts like a switch, turning off critical genes that would normally regulate cell growth and differentiation. Transcriptional repression involves proteins binding to DNA, either directly or indirectly, to inhibit the transcription of specific genes or gene sets. Think of it as a roadblock preventing the cell from reading and using the instructions encoded in those genes. AZISHIL 100MG INJECTION, in its active form, targets both RNA and DNA within rapidly dividing cells.
• By binding to these nucleic acids, AZISHIL 100MG INJECTION disrupts their normal function. It interferes with the cell's ability to replicate its DNA, transcribe RNA, and ultimately produce the proteins necessary for cell survival and proliferation. This interference leads to a toxic effect specifically on cancer cells, which are characterized by their uncontrolled and rapid division. The drug essentially sabotages the cellular machinery responsible for cancer's aggressive growth. AZISHIL 100MG INJECTION preferentially affects these fast-growing cells, offering a targeted approach to cancer treatment while minimizing damage to healthy, slower-growing tissues. This targeted action is crucial for reducing side effects and improving patient outcomes.
• The mechanism of AZISHIL 100MG INJECTION provides a crucial advantage in treating MDS and AML. By targeting the fundamental processes of DNA and RNA activity, the drug effectively hinders the proliferation of cancerous cells. This approach offers a pathway to manage and potentially eradicate the disease, leading to improved patient prognosis.

• Administer AZISHIL 100MG INJECTION strictly under the guidance and supervision of a qualified physician or healthcare professional. Self-administration is strongly discouraged due to the potential for complications and the need for accurate dosage adjustments.
• The dosage of AZISHIL 100MG INJECTION will be determined by your physician based on a comprehensive evaluation of your individual health profile. Factors considered include your height, weight, overall health condition, and the specific medical condition being treated. Adhering to the prescribed dosage is crucial for achieving optimal therapeutic outcomes and minimizing the risk of adverse effects.
• AZISHIL 100MG INJECTION is administered subcutaneously, meaning it is injected beneath the skin. The injection site typically includes the thigh, stomach (abdomen), or upper arm. Your healthcare provider will instruct you on the proper injection technique and the rotation of injection sites to prevent skin irritation and ensure consistent absorption of the medication.
• Before each injection, carefully inspect the AZISHIL 100MG INJECTION solution for any particulate matter or discoloration. Do not use the solution if it appears cloudy, discolored, or contains visible particles. Use a new, sterile syringe and needle for each injection to prevent contamination.
• If you experience any pain, swelling, redness, or other adverse reactions at the injection site, notify your physician immediately. They can assess the situation and provide appropriate medical advice.
• It is important to maintain open communication with your physician throughout the course of treatment with AZISHIL 100MG INJECTION. Report any changes in your health status, any new medications you are taking, or any concerns you may have. Regular follow-up appointments are essential for monitoring your progress and ensuring the safe and effective use of this medication.